Global Medical REIT Files 8-K on Material Agreement

TL;DR

GMED signs new material deal, creating financial obligation. Details in 8-K.

AI Summary

Global Medical REIT Inc. filed an 8-K on October 8, 2025, reporting the entry into a material definitive agreement and the creation of a direct financial obligation. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Maryland and headquartered in Bethesda, MD.

Why It Matters

This 8-K filing indicates a significant new agreement and potential financial obligation for Global Medical REIT, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — The filing pertains to a material definitive agreement and financial obligation, which inherently carries some level of risk and requires further investigation into the specifics.

Key Players & Entities

• Global Medical REIT Inc. (company) — Registrant
• October 8, 2025 (date) — Date of earliest event reported
• Maryland (jurisdiction) — State of Incorporation
• 464757266 (ein) — Employer Identification Number
• 001-37815 (sec_file_number) — SEC File Number
• 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA, MD 20814 (address) — Business and Mail Address

FAQ

Key Financial Figures

• $0.001 — h registered: Common Stock, par value $0.001 per share GMRE NYSE Series A Pref
• $400 million — tends the maturity date of the existing $400 million revolver component of the credit facili
• $350 million — Extends the maturity of the existing $350 million term loan, dividing it into three term
• $100 million — e term loans structured as follows: o $100 million term loan maturing in October 2029; o
• $150 million — loan maturing in October 2030; and o $150 million term loan maturing in April 2031; and
• $500 million — loan that matures in February 2028, and $500 million accordion feature remains unchanged in

Filing Documents

• tm2528281d1_8k.htm (8-K) — 39KB
• tm2528281d1_ex10-1.htm (EX-10.1) — 987KB
• tm2528281d1_ex99-1.htm (EX-99.1) — 17KB
• image_001.jpg (GRAPHIC) — 3KB
• 0001104659-25-097935.txt ( ) — 1464KB
• gmre-20251008.xsd (EX-101.SCH) — 3KB
• gmre-20251008_def.xml (EX-101.DEF) — 26KB
• gmre-20251008_lab.xml (EX-101.LAB) — 36KB
• gmre-20251008_pre.xml (EX-101.PRE) — 25KB
• tm2528281d1_8k_htm.xml (XML) — 5KB

01

Item 1.01 Entry into a Material Definitive Agreement. On October 8, 2025, Global Medical REIT Inc. (the "Company"), Global Medical REIT L.P. (the "Operating Partnership"), as borrower, and certain subsidiaries of the Operating Partnership (such subsidiaries, the "Subsidiary Guarantors") entered into a third amended and restated credit agreement (the "Third A&R Credit Facility") with JPMorgan Chase Bank, N.A., as administrative agent, which contains the following material amendments to the Company's previous credit facility: Extends the maturity date of the existing $400 million revolver component of the credit facility to October 2029 with two, six-month extension options available at the Company's election to extend the maturity to October 2030; and Extends the maturity of the existing $350 million term loan, dividing it into three term loans structured as follows: o $100 million term loan maturing in October 2029; o $100 million term loan maturing in October 2030; and o $150 million term loan maturing in April 2031; and Removes the previous 0.10% (10 basis point) secured overnight financing rate ("SOFR") credit spread adjustment on all credit facility borrowings. The credit facility's pricing grid, $150 million term loan that matures in February 2028, and $500 million accordion feature remains unchanged in the Third A&R Credit Facility. The above description of the terms and conditions of the Third A&R Credit Facility is only a summary of the material amendments to the Company's previous credit facility and is not intended to be a complete description of the terms and conditions. All of the terms and conditions of the Third A&R Credit Facility are set forth in the Third A&R Credit Facility, which is filed as Exhibit 10.1 hereto, and is incorporated herein by reference.

03

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information disclosed above in Item 1.01 is incorporated by reference.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On October 8, 2025, the Company issued a press release announcing the Third A&R Credit Facility. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. The information under Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Third Amended and Restated Credit Agreement, dated October 8, 2025, by and among Global Medical REIT L.P., Global Medical REIT Inc., the certain subsidiaries from time-to-time party thereto as guarantors, and JPMorgan Chase Bank, N.A., as administrative agent, and the several banks, financial institutions and other entities from time-to-time party thereto as lenders 99.1 Press Release dated October 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Global Medical REIT Inc. By: /s/ Jamie A. Barber Jamie A. Barber Secretary and General Counsel Date: October 8, 2025

View Full Filing

View this 8-K filing on SEC EDGAR